Type I HAE
Showing 1 - 25 of >10,000
Hereditary Angioedema Trial (KVD900 600 mg)
Not yet recruiting
- Hereditary Angioedema
- KVD900 600 mg
- (no location specified)
Aug 19, 2022
Lanadelumab in Teenagers and Hereditary Angioedema (HAE)
Not yet recruiting
- Hereditary Angioedema (HAE)
- No Intervention
-
London, England, United KingdomBarts Health NHS Trust
Jul 20, 2022
Hereditary Angioedema Trial (KVD900 600 mg)
Not yet recruiting
- Hereditary Angioedema
- KVD900 600 mg
- (no location specified)
Aug 17, 2022
Teenagers and Hereditary Angioedema Type I or Type II Who Use
Completed
- Hereditary Angioedema (HAE)
-
Graz, Austria
- +19 more
Jan 12, 2023
Biomarker for Hereditary AngioEdema Disease
Completed
- C1 Esterase Inhibitor Deficiency
- +7 more
-
Yerevan, Armenia
- +6 more
Mar 23, 2022
Lanadelumab in Persons With Hereditary Angioedema Type I or II
Recruiting
- Hereditary Angioedema (HAE)
-
Wien, Austria
- +19 more
Dec 13, 2021
Angioedema, Hereditary, Types I and II Trial in Worldwide (KVD824, Placebo to KVD824)
Recruiting
- Angioedema, Hereditary, Types I and II
- KVD824
- Placebo to KVD824
-
Birmingham, Alabama
- +34 more
Aug 9, 2022
Lanadelumab in Persons With Hereditary Angioedema in Poland
Recruiting
- Hereditary Angioedema (HAE)
-
Wrocław, Dolnośląskie, Poland
- +13 more
Jun 15, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium
Recruiting
- Hereditary Angioedema
- +11 more
- PHA-022121 low dose
- +3 more
-
Birmingham, Alabama
- +7 more
Dec 5, 2022
Lanadelumab in Persons With Hereditary Angioedema Type I or II
Active, not recruiting
- Hereditary Angioedema (HAE)
-
Birmingham, Alabama
- +28 more
Dec 17, 2021
Hereditary Angioedema Trial in Canada, Puerto Rico, United States (Placebo, KVD900 600 mg, KVD900 300 mg)
Recruiting
- Hereditary Angioedema
- Placebo
- +2 more
-
Birmingham, Alabama
- +14 more
Jun 16, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +21 more
Aug 11, 2022
Hereditary Angioedema (HAE) Trial in Worldwide (DX-2930 - 300mg/2wk, DX-2930 - 300mg/4wk, DX-2930 - 150mg/4wk)
Completed
- Hereditary Angioedema (HAE)
- DX-2930 - 300mg/2wk
- +3 more
-
Birmingham, Alabama
- +40 more
May 13, 2021
Burden of Illness and Treatment Patterns in Teenagers and
Recruiting
- Hereditary Angioedema
-
Warszawa, Poland
- +4 more
May 6, 2022
Complex Regional Pain Syndrome Type I Trial (Mirror Therapy exercise)
Completed
- Complex Regional Pain Syndrome Type I
- Mirror Therapy exercise
- (no location specified)
Oct 20, 2023
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Active, not recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +35 more
Aug 23, 2022
Hypertension, Blood Pressure, Systolic Hypertension Trial in Seoul (CART-I Plus)
Recruiting
- Hypertension
- +6 more
- CART-I Plus
-
Seoul, Korea, Republic ofSeoul National Univesity Hospital
Oct 11, 2023
Hereditary Angioedema Trial in Netherlands, United States (IONIS-PKK-LRx, Placebo)
Type1diabetes Trial in Cairo (Detection of RAGE gene polymorphism (rs1800625))
Completed
- Type1diabetes
- Detection of RAGE gene polymorphism (rs1800625)
-
Cairo, EgyptNational Institute of Diabetes and Endocrinology's
May 23, 2023
Diabetes, Type 1 Trial in Abu Dhabi (Insulin injection and blood glucose)
Completed
- Diabetes Mellitus, Type 1
- Insulin injection and blood glucose
-
Abu Dhabi, United Arab EmiratesHisham Ibrahim
Sep 20, 2023
Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)
Not yet recruiting
- Fatty Liver, Nonalcoholic
- SGLT2 inhibitor
- (no location specified)
Oct 31, 2023
Mucopolysaccharidosis III-A Trial in Hamburg (JR-441)
Recruiting
- Mucopolysaccharidosis III-A
-
Hamburg, GermanyUniversitätsklinikum Hamburg-Eppendorf
Oct 18, 2023
Heart Failure Trial in New York (I-TRANSFER-HF)
Not yet recruiting
- Heart Failure
- I-TRANSFER-HF
-
New York, New York
- +1 more
Oct 31, 2023
Dental Implant Trial (Type I Dental implant placement., Type II Dental implant placement., Type III/IV dental implant
Not yet recruiting
- Dental Implant
- Type I Dental implant placement.
- +2 more
- (no location specified)
Aug 4, 2023